Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Pharm Res ; 37(6): 103, 2020 May 24.
Artigo em Inglês | MEDLINE | ID: mdl-32448925

RESUMO

PURPOSE: We aimed to assess intranasal (IN) epinephrine effects on cerebrospinal fluid (CSF) absorption, nasal mucosa quality, plasma epinephrine pharmacokinetics (PK), and cardiovascular changes in dogs. METHODS: CSF epinephrine concentration was measured and nasal mucosa quality was evaluated after IN epinephrine 4 mg and one or two 4 mg doses (21 min apart), respectively. Maximum plasma concentration [Cmax], time to Cmax [Tmax], area under the curve from 0 to 120 min [AUC0-120], and cardiovascular effects were evaluated after epinephrine IN (4 and 5 mg) and intramuscular (IM; 0.3 mg). Clinical observations were assessed. RESULTS: After epinephrine IN, there were no changes in CSF epinephrine or nasal mucosa. Cmax, Tmax, and AUC1-120 were similar following epinephrine IN and IM. Epinephrine IN versus IM increased plasma epinephrine at 1 min (mean ± SEM, 1.15 ± 0.48 for 4 mg IN and 1.7 ± 0.72 for 5 mg IN versus 0.47 ± 0.11 ng/mL for 0.3 mg IM). Epinephrine IN and IM produced similar heart rate and ECG results. Clinical observations included salivation and vomiting. CONCLUSIONS: Epinephrine IN did not alter CSF epinephrine or nasal tissue and had similar cardiovascular effects as epinephrine IM. Epinephrine IN rapidly increased plasma epinephrine concentration versus epinephrine IM.


Assuntos
Sistema Cardiovascular/efeitos dos fármacos , Líquido Cefalorraquidiano/metabolismo , Epinefrina/administração & dosagem , Mucosa Nasal/efeitos dos fármacos , Administração Intranasal/efeitos adversos , Anafilaxia/tratamento farmacológico , Animais , Área Sob a Curva , Cães , Avaliação Pré-Clínica de Medicamentos , Epinefrina/sangue , Epinefrina/líquido cefalorraquidiano , Epinefrina/farmacocinética , Feminino , Frequência Cardíaca/efeitos dos fármacos , Humanos , Injeções Intramusculares , Masculino , Modelos Animais , Mucosa Nasal/diagnóstico por imagem
2.
J Am Vet Med Assoc ; 242(7): 959-62, 2013 Apr 01.
Artigo em Inglês | MEDLINE | ID: mdl-23517208

RESUMO

OBJECTIVE: To determine the prevalence of urinary incontinence in spayed female dogs and categorize affected dogs by age at time of ovariohysterectomy, number of litters prior to ovariohysterectomy, body weight, treatment of affected dogs, and severity of incontinence and to determine associations among these variables. DESIGN: Retrospective case series. ANIMALS: 566 ovariohysterectomized dogs. PROCEDURES: An attempt was made to contact owners of 912 dogs ovariohysterectomized between January 2003 and January 2008 to discuss presence or absence of urinary incontinence. The actual number of responders was 566. Those owners with incontinent pets received a questionnaire further assessing degree of incontinence, diagnostic testing, treatment, and history. RESULTS: The prevalence of acquired urinary incontinence was determined to be 5.12% (29/566 dogs) on the basis of results of phone surveys and questionnaires. There was no significant difference in the age at time of ovariohysterectomy between incontinent and continent groups. A significant association was found between body weight and incontinence, with incontinence rates higher among larger (≥ 15 kg [33.1 lb]) dogs. Larger dogs were approximately 7 times as likely (OR, 7.2 [95% confidence interval, 2.5 to 21.1]) to develop acquired urinary incontinence, compared with small dogs (< 15 kg). CONCLUSIONS AND CLINICAL RELEVANCE: Although acquired urinary incontinence in female dogs is known to be associated with ovariohysterectomy, the prevalence in this study was low.


Assuntos
Doenças do Cão/etiologia , Histerectomia/veterinária , Incontinência Urinária/veterinária , Animais , Coleta de Dados , Cães , Feminino , Histerectomia/efeitos adversos , Estudos Retrospectivos , Inquéritos e Questionários , Incontinência Urinária/etiologia
3.
J Vet Emerg Crit Care (San Antonio) ; 20(6): 595-600, 2010 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-21166981

RESUMO

OBJECTIVE: To describe the successful management of acute mesenteric ischemia (AMI) in a dog. CASE SUMMARY: An 11-year-old, 21.4kg, male castrated Rough-Coated Collie was referred for evaluation of an acute abdomen following sustaining injuries in a vehicular accident. On presentation to the hospital, clinicopathologic assessments were within normal limits and distended intestinal loops were evident on abdominal palpation. Plain and contrast radiography demonstrated diffusely distended gas-filled intestinal loops with a delayed barium transit time. Emergency surgical exploration was performed. The cecum and the proximal two-thirds of the colon were dark purple to black in color and there were no palpable pulses in the mesenteric arteries associated with the cecum and colon. The cecum and proximal two-thirds of the colon were resected and an ileocolic anastomosis was performed. The dog recovered well from surgery and was discharged 2 days later. Histopathologic examination was consistent with AMI. NEW OR UNIQUE INFORMATION PROVIDED: AMI is uncommonly reported in human medicine and is a rare complication from even minor blunt abdominal trauma. This is the first reported case of trauma-associated AMI in a dog.


Assuntos
Doenças do Cão/etiologia , Doenças do Cão/cirurgia , Cães/lesões , Cães/cirurgia , Isquemia/veterinária , Doenças Vasculares/veterinária , Animais , Doenças do Cão/diagnóstico por imagem , Isquemia/diagnóstico por imagem , Isquemia/etiologia , Isquemia/cirurgia , Masculino , Isquemia Mesentérica , Radiografia , Resultado do Tratamento , Doenças Vasculares/diagnóstico por imagem , Doenças Vasculares/etiologia , Doenças Vasculares/cirurgia
4.
J Nutr ; 132(8 Suppl): 2419S-2423S, 2002 08.
Artigo em Inglês | MEDLINE | ID: mdl-12163704

RESUMO

In this study we examine the effect of the phytoestrogen genistein on DNA methylation. DNA methylation is thought to inhibit transcription of genes by regulating alterations in chromatin structure. Estrogenic compounds have been reported to regulate DNA methylation in a small number of studies. Additionally, phytoestrogens are believed to affect progression of some human diseases, such as estrogen-dependent cancers, osteoporosis and cardiovascular disease. Specifically, our working hypothesis is that certain soy phytoestrogens, such as genistein, may be involved in preventing the development of certain prostate and mammary cancers by maintaining a protective DNA methylation profile. The objective of the present study is to use mouse differential methylation hybridization (DMH) arrays to test for changes in the methylation status of the cytosine guanine dinucleotide (CpG) islands in the mouse genome by examining how these methylation patterns are affected by genistein. Male mice were fed a casein-based diet (control) or the same diet containing 300 mg genistein/kg according to one of four regimens: control diet for 4 wk, genistein diet for 4 wk, control diet for 2 wk followed by genistein diet for 2 wk and genistein diet for 2 wk followed by control diet for 2 wk. DNA from liver, brain and prostate were then screened with DMH arrays. Clones with methylation differences were sequenced and compared with known sequences. In conclusion, consumption of genistein diet was positively correlated with changes in prostate DNA methylation at CpG islands of specific mouse genes.


Assuntos
Metilação de DNA , Genisteína/farmacologia , Animais , Sequência de Bases , Ilhas de CpG , DNA , Humanos , Masculino , Camundongos , Camundongos Endogâmicos C57BL , Hibridização de Ácido Nucleico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...